Literature DB >> 25388646

Physical impairment in patients with idiopathic inflammatory myopathies is associated with the American College of Rheumatology functional status measure.

Beatriz Y Hanaoka1, Laura C Cleary1, Douglas E Long1, Archana Srinivas1, Kirk A Jenkins1, Heather M Bush2, Catherine P Starnes2, Mathew Rutledge2, Jidan Duan2, Qian Fan2, Natasha Fraser1, Leslie J Crofford3.   

Abstract

The goals of this study were to assess the predictive value of chart-abstracted American College of Rheumatology functional status (ACR-FS) with patient-reported ACR-FS and to relate it with measures of muscle function in a single-institution cohort of patients with idiopathic inflammatory myopathies (IIMs). Demographic and clinical data of 102 patients with IIMs regularly followed in the Rheumatology and Neurology Clinics at the University of Kentucky Medical Center between 2006 and 2012 were obtained through retrospective chart review. Clinical and functional status evaluation, muscle performance testing, and body composition measures were performed on a subset of 21 patients. ACR-FS was obtained by both chart abstraction and direct patient report. Spearman's correlations were used to examine the relationship of ACR-FS derived from chart abstraction with direct patient report, as well as the relationship of measures of physical function and body composition with ACR-FS. ACR-FS derived from chart abstraction was significantly correlated with ACR-FS derived from direct patient report (ρ = 0.78, p < 0.001). ACR-FS derived from chart abstraction was also significantly correlated with patient-reported physical function (ρ = -0.71, p < 0.001) and physical activity (ρ = -0.58, p < 0.05), manual muscle testing (ρ = -0.66, p < 0.01), and skeletal muscle endurance as measured by the functional index-2 test (shoulder flexion ρ = -0.62, p < 0.01; hip flexion ρ = -0.65, p < 0.0; heel lift ρ = -0.67, p < 0.01; and toe lift ρ = -0.68, p < 0.01). The ACR-FS is a simple measure of disability that can be used in chart abstraction studies involving IIM patients. We have demonstrated that ACR-FS correlates well with muscle performance tests of strength and endurance.

Entities:  

Keywords:  Functional status; Idiopathic inflammatory myopathy; Physical function

Mesh:

Year:  2014        PMID: 25388646      PMCID: PMC5244815          DOI: 10.1007/s10067-014-2821-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Inclusion body myositis.

Authors:  Rabi Tawil; Robert C Griggs
Journal:  Curr Opin Rheumatol       Date:  2002-11       Impact factor: 5.006

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK.

Authors:  Hector Chinoy; Fiona Salway; Sally John; Noreen Fertig; Brian D Tait; Chester V Oddis; William E R Ollier; Robert G Cooper
Journal:  Ann Rheum Dis       Date:  2007-04-03       Impact factor: 19.103

5.  A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.

Authors:  Fieke M Cox; Maarten J Titulaer; Jacob K Sont; Axel R Wintzen; Jan J G M Verschuuren; Umesh A Badrising
Journal:  Brain       Date:  2011-09-09       Impact factor: 13.501

6.  Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis.

Authors:  A Ponyi; G Borgulya; T Constantin; A Váncsa; L Gergely; K Dankó
Journal:  Rheumatology (Oxford)       Date:  2004-09-20       Impact factor: 7.580

7.  Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.

Authors:  S Lillioja; A A Young; C L Culter; J L Ivy; W G Abbott; J K Zawadzki; H Yki-Järvinen; L Christin; T W Secomb; C Bogardus
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

8.  Frailty in older persons: multisystem risk factors and the Frailty Risk Index (FRI).

Authors:  Tze Pin Ng; Liang Feng; Ma Shwe Zin Nyunt; Anis Larbi; Keng Bee Yap
Journal:  J Am Med Dir Assoc       Date:  2014-04-17       Impact factor: 4.669

Review 9.  Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).

Authors:  Lisa G Rider; Victoria P Werth; Adam M Huber; Helene Alexanderson; Anand Prahalad Rao; Nicolino Ruperto; Laura Herbelin; Richard Barohn; David Isenberg; Frederick W Miller
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

10.  Nonvolitional assessment of muscle endurance in idiopathic inflammatory myopathies: there is no relationship between patient-reported fatigue and muscle fatigability.

Authors:  Richard Campbell; Patrick Gordon; Katie Ward; Charles Reilly; David L Scott; Gerrard F Rafferty
Journal:  Muscle Nerve       Date:  2014-09       Impact factor: 3.217

View more
  4 in total

1.  Does computed tomography-based muscle density predict muscle function and health-related quality of life in patients with idiopathic inflammatory myopathies?

Authors:  Laura C Cleary; Leslie J Crofford; Douglas Long; Richard Charnigo; Jody Clasey; Francesca Beaman; Kirk A Jenkins; Natasha Fraser; Archana Srinivas; Nicole Dhaon; Beatriz Y Hanaoka
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-07       Impact factor: 4.794

2.  Muscle endurance deficits in myositis patients despite normal manual muscle testing scores.

Authors:  David R Amici; Iago Pinal-Fernandez; Ruben Pagkatipunan; Albert Mears; Rebecca de Lorenzo; Eleni Tiniakou; Jemima Albayda; Julie J Paik; Thomas E Lloyd; Lisa Christopher-Stine; Andrew L Mammen; Tae Chung
Journal:  Muscle Nerve       Date:  2018-12-18       Impact factor: 3.217

Review 3.  Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review.

Authors:  Rossella Talotta; Irene Porrello; Roberto Restuccia; Ludovico Magaudda
Journal:  Clin Rheumatol       Date:  2021-10-19       Impact factor: 2.980

4.  Therapeutic management of immune-mediated necrotizing myositis.

Authors:  Emma Weeding; Eleni Tiniakou
Journal:  Curr Treatm Opt Rheumatol       Date:  2021-03-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.